(Q52875756)
Statements
Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial. (English)
Matthias Mölle
Helmut Oettle
Hanno Riess
Jens M Stieler
Gerhard Heil
Ingo Schwaner
Jörg Seraphin
Martin Görner
Tim F Greten
Volker Lakner
Sven Bischoff
Marianne Sinn
Bernd Dörken
Uwe Pelzer
30 June 2014
32
23
2423-2429